
Precision Neuroscience raises $250M for its FDA-cleared brain-computer interface, backed by Bill Ackman
Precision Neuroscience closed an oversubscribed $250M Series D led by Pershing Square for its removable Layer 7 brain-computer interface — already used in 100+ patient procedures across 18 hospitals, unlike Neuralink's permanent implants.










